Valeant International Bermuda
6Patents
6Active
6Granted
46Portfolio score
Filing activity: Jun 13, 2007 → Oct 17, 2012 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8932628B2 | Modified release formulations of a bupropion salt | Chemistry; Metallurgy | 125 | Active |
| US8323692B2 | Controlled release dosage forms | Human Necessities | 29 | Active |
| US8414657B2 | Method for subcutaneous or intradermal injection | Human Necessities | 8 | Active |
| US8349900B2 | Bupropion hydrobromide polymorphs | Chemistry; Metallurgy | 1 | Active |
| US8354453B2 | Bupropion hydrobromide and therapeutic applications | Human Necessities | 0 | Active |
| US8604085B2 | Bupropion hydrobromide polymorphs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.